Rutgers Pilot for PREDICT- Patient LAB Test

Rutgers The State University of New Jersey

Status: Completed

Conditions: SARS-CoV2 Infection

Treatments: Device: Testing for SARS CoV2 RNA

Study type: Interventional

Funder types: Other; NIH

Identifiers

NCT05607043

Pro2020002999

X01DE030407 (Other Identifier)

Details and patient eligibility

About

A pilot study was initiated to assess feasibility of testing asymptomatic dental patients presenting to the Oral Medicine Clinic at Rutgers School of Dental Medicine for SARS-CoV-2 viral RNA using an FDA approved RT-PCR test for SARS-CoV2- an RNA RT-PCR assay (Accurate Diagnostics)

Full description

Patients with upcoming dental appointments at the Oral Medicine clinic at Rutgers School of Dental Medicine were contacted to solicit interest in participating in a pilot study to assess feasibility of testing asymptomatic dental patients for SARS CoV 2 infection using an RNA RT-PCR assay. Interested subjects completed a previsit survey after confirming their interest electronically. Subsequently, they received kit to collect their saliva sample at home along with instructions on how to do so. They were directed to drop off their saliva samples for testing at the dental clinic and signed the consent form at that time. After confirming a negative result, the patients were subsequently triaged over the phone for any symptoms and the following day, presented for their dental visit.

On the day of their visit, they were triaged, completed their dental visit and were surveyed to get their feedback on the study procedures and their perceptions of safety.

Enrollment: 11 patients

Sex: All

Ages: 18 to 99 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Adult 18 years or older; reporting to the Rutgers School of Dental Medicine for a dental visit

Exclusion criteria

• Previous participation

Trial design

Primary purpose: Other

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

11 participants in 1 patient group

SARS-CoV-2 testing

Other group

Description:

There is only one arm in this study- the study is a non-randomized pilot. All the subjects will be tested for SARS CoV 2 viral infection as described.

Treatment:

Device: Testing for SARS CoV2 RNA